Veralipride msds| properties| cas no| molecular formula | WorldOfChemicals

Veralipride Properties

Veralipride

Kanox 6920-Product_Structure
Molecule Structure Image

Description

 

Veralipride is a benzamide neuroleptic medicine indicated in the treatment of vasomotor symptoms associated with the menopause. It was first authorised for use in 1979. It has never gained approval in the United States. On September 2006, it was withdrawn from the Spanish market. As a result, the European Commission referred the matter to the European Medicines Agency (EMA). On July 2007, the EMA recommended the withdrawal of marketing authorisations for veralipride.

Chemical Properties

CAS Number 66644-81-3
Density 1.23 g/cm3
EINECS Number 266-435-5
IUPAC Name N-[(1-Allylpyrrolidin-2-yl)methyl]-5-(aminosulfonyl)-2,3-dimethoxybenzamide
InChI 1S/C17H25N3O5S/c1-4-7-20-8-5-6-12(20)11-19-17(21)14-9-13(26(18,22)23)10-15(24-2)16(14)25-3/h4,9-10,12H,1,5-8,11H2,2-3H3,(H,19,21)(H2,18,22,23)
InChIKey RYJXBGGBZJGVQF-UHFFFAOYSA-N
Molar Mass 383.46 g/mol
Molecular Formula C17H25N3O5S
Synonyms Benzamide,5-(aminosulfonyl)-2,3-dimethoxy-N-[[1-(2-propen-1-yl)-2-pyrrolidinyl]methyl]-;Veralipride;Agreal;Agradil